Perinatal and early infant outcomes after first‐versus second‐generation integrase strand transfer inhibitor use in pregnancy
There were no significant associations between second-generation INSTIs and adverse perinatal outcomes compared to first-generation INSTIs. These findings support the ongoing use of second-generation INSTIs in pregnancy with continued careful surveillance of perinatal outcomes.
Authors
- Laura Sauvé
- Isabelle Boucoiran (ORCID: https://orcid.org/0000-0001-9545-6024)
- Ari Bitnun
- Alena Tse‐Chang (ORCID: https://orcid.org/0000-0002-6645-6620)
- Rosa Balleny
- Jeannette L. Comeau
- J Wong
- Fatima Kakkar
- Deborah Money
- Terry Lee
- Jason Brophy
- Joel Singer
Institutions
- Dalhousie University (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- University of Alberta (CA)
- University of Toronto (CA)
- University of Saskatchewan (CA)
- Centre for Advancing Health Outcomes (CA)
- HIV Legal Network (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- HIV Medicine
- Published
- 2026-02-10
- DOI
- https://doi.org/10.1111/hiv.70206
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00